Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Death domain containing protein | 0.0017 | 0.1368 | 0.2886 |
Schistosoma mansoni | protein kinase C | 0.0007 | 0.0125 | 0.0218 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.3579 | 0.6261 |
Echinococcus multilocularis | unc 13 (munc13) | 0.0007 | 0.0125 | 0.0125 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0483 | 0.0846 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0483 | 0.102 |
Onchocerca volvulus | 0.001 | 0.0483 | 0.2884 | |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.001 | 0.0483 | 0.1057 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0007 | 0.0125 | 0.0273 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.001 | 0.0483 | 0.1057 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0053 | 0.5716 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 38 | 0.0008 | 0.027 | 0.027 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0053 | 0.5716 | 1 |
Echinococcus granulosus | ankyrin repeat and death domain containing protein | 0.0017 | 0.1368 | 0.1368 |
Brugia malayi | hypothetical protein | 0.0036 | 0.3579 | 0.7548 |
Schistosoma mansoni | ankyrin 23/unc44 | 0.0017 | 0.1368 | 0.2394 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0038 | 0.3869 | 0.3869 |
Loa Loa (eye worm) | AGC/DMPK/GEK protein kinase | 0.0008 | 0.027 | 0.0591 |
Onchocerca volvulus | Netrin receptor homolog | 0.0017 | 0.1368 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.001 | 0.0483 | 0.0846 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.001 | 0.0483 | 0.1057 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0.0483 | 0.2884 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.001 | 0.0483 | 0.0483 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.001 | 0.0483 | 0.1057 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | death domain containing protein | 0.0017 | 0.1368 | 0.1368 |
Brugia malayi | Protein kinase domain containing protein | 0.0008 | 0.027 | 0.057 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0008 | 0.027 | 0.0591 |
Brugia malayi | nuclear receptor NHR-88 | 0.001 | 0.0483 | 0.102 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.001 | 0.0483 | 0.102 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0483 | 0.0483 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.001 | 0.0483 | 0.0846 |
Schistosoma mansoni | unc-13 (munc13) | 0.0007 | 0.0125 | 0.0218 |
Loa Loa (eye worm) | AGC/PKN protein kinase | 0.0008 | 0.027 | 0.0591 |
Loa Loa (eye worm) | AGC/RSK/MSK protein kinase | 0.0008 | 0.027 | 0.0591 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1368 | 0.2394 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0008 | 0.027 | 0.0473 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3579 | 1 |
Echinococcus granulosus | Ankyrin | 0.0018 | 0.1386 | 0.1386 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0483 | 0.102 |
Schistosoma mansoni | serine/threonine kinase | 0.0008 | 0.027 | 0.0473 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.001 | 0.0483 | 0.0483 |
Brugia malayi | Protein kinase domain containing protein | 0.0018 | 0.139 | 0.2931 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.3869 | 0.846 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0038 | 0.3869 | 0.3869 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.001 | 0.0483 | 0.102 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | protein kinase C gamma type | 0.0048 | 0.5011 | 0.5011 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0008 | 0.027 | 0.027 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0483 | 0.0483 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Echinococcus granulosus | protein kinase c iota type | 0.0014 | 0.0975 | 0.0975 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0483 | 0.102 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0483 | 0.0483 |
Brugia malayi | Protein kinase domain containing protein | 0.0008 | 0.027 | 0.057 |
Echinococcus multilocularis | ribosomal protein s6 kinase beta 1 | 0.0008 | 0.027 | 0.027 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.001 | 0.0483 | 0.0483 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0008 | 0.027 | 0.057 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0089 | 1 | 1 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.001 | 0.0483 | 0.0846 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3579 | 1 |
Schistosoma mansoni | netrin receptor unc5 | 0.0017 | 0.1368 | 0.2394 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0483 | 0.0846 |
Brugia malayi | ecdysteroid receptor | 0.001 | 0.0483 | 0.102 |
Toxoplasma gondii | AGC kinase | 0.0008 | 0.027 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0008 | 0.027 | 0.057 |
Brugia malayi | Uncoordinated protein 44 | 0.0017 | 0.1368 | 0.2886 |
Echinococcus multilocularis | netrin receptor unc 5 | 0.0017 | 0.1368 | 0.1368 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.3579 | 0.3579 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.001 | 0.0483 | 0.0846 |
Schistosoma mansoni | unc-13 (munc13) | 0.0007 | 0.0125 | 0.0218 |
Echinococcus granulosus | FTZ F1 alpha | 0.001 | 0.0483 | 0.0483 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0008 | 0.027 | 0.5 |
Echinococcus granulosus | Ribosomal protein S6 kinase beta 2 | 0.0008 | 0.027 | 0.027 |
Echinococcus granulosus | ribosomal protein S6 kinase alpha 3 | 0.0008 | 0.027 | 0.027 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0008 | 0.027 | 0.027 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | steroid hormone receptor | 0.001 | 0.0483 | 0.1057 |
Schistosoma mansoni | nuclear hormone receptor | 0.001 | 0.0483 | 0.0846 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.001 | 0.0483 | 0.102 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0018 | 0.1386 | 0.2425 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | netrin receptor unc 5 | 0.0017 | 0.1368 | 0.1368 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3579 | 1 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.001 | 0.0483 | 0.0846 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.001 | 0.0483 | 0.102 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.001 | 0.0483 | 0.102 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0038 | 0.3869 | 0.3869 |
Brugia malayi | Hr1 repeat family protein | 0.0008 | 0.027 | 0.057 |
Loa Loa (eye worm) | hypothetical protein | 0.0008 | 0.027 | 0.0591 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.1368 | 0.2886 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0.0483 | 0.2884 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.4573 | 1 |
Echinococcus granulosus | C2 calcium dependent membrane targeting | 0.0007 | 0.0125 | 0.0125 |
Echinococcus multilocularis | Ankyrin | 0.0018 | 0.1386 | 0.1386 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.1386 | 0.3031 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0015 | 0.1121 | 0.1121 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0015 | 0.1121 | 0.1961 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | AGC/NDR protein kinase | 0.0008 | 0.027 | 0.0591 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0008 | 0.027 | 0.0473 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.3579 | 0.3579 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0483 | 0.102 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0008 | 0.027 | 0.027 |
Echinococcus granulosus | unc 13 munc13 | 0.0007 | 0.0125 | 0.0125 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.3579 | 0.6261 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.001 | 0.0483 | 0.0846 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0483 | 0.0483 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0483 | 0.0483 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3579 | 1 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0048 | 0.5011 | 0.5011 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0.0483 | 0.2884 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0053 | 0.5716 | 0.5716 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.001 | 0.0483 | 0.0846 |
Echinococcus multilocularis | protein kinase c iota type | 0.0014 | 0.0975 | 0.0975 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Echinococcus multilocularis | Ribosomal protein S6 kinase beta 2 | 0.0008 | 0.027 | 0.027 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Echinococcus multilocularis | ankyrin repeat and death domain containing protein | 0.0017 | 0.1368 | 0.1368 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.001 | 0.0483 | 0.0846 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1368 | 0.2992 |
Echinococcus granulosus | ribosomal protein s6 kinase beta 1 | 0.0008 | 0.027 | 0.027 |
Brugia malayi | nuclear hormone receptor | 0.001 | 0.0483 | 0.102 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0483 | 0.102 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0483 | 0.0483 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0483 | 0.0483 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.0008 | 0.027 | 0.027 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.001 | 0.0483 | 0.102 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Echinococcus granulosus | NDR protein kinase | 0.0008 | 0.027 | 0.027 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.001 | 0.0483 | 0.102 |
Schistosoma mansoni | coup transcription factor | 0.001 | 0.0483 | 0.0846 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0008 | 0.027 | 0.0591 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.001 | 0.0483 | 0.0483 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.001 | 0.0483 | 0.102 |
Echinococcus multilocularis | C2 calcium dependent membrane targeting | 0.0007 | 0.0125 | 0.0125 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.001 | 0.0483 | 0.0846 |
Brugia malayi | Protein kinase c protein 2 | 0.0045 | 0.4741 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0008 | 0.027 | 0.0473 |
Trichomonas vaginalis | AGC family protein kinase | 0.0008 | 0.027 | 1 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.0008 | 0.027 | 0.0591 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.1368 | 0.2992 |
Schistosoma mansoni | atypical protein kinase C | 0.0014 | 0.0975 | 0.1705 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0008 | 0.027 | 0.0473 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0483 | 0.102 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.001 | 0.0483 | 0.102 |
Echinococcus multilocularis | FTZ F1 alpha | 0.001 | 0.0483 | 0.0483 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0015 | 0.1121 | 0.1121 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Brugia malayi | steroid hormone receptor | 0.001 | 0.0483 | 0.102 |
Brugia malayi | protein kinase C II. | 0.0015 | 0.1121 | 0.2364 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0483 | 0.1057 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0039 | 0.4037 | 0.8827 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0053 | 0.5716 | 0.5716 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0015 | 0.1121 | 0.2451 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.001 | 0.0483 | 0.102 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
1/n (binding) | = 0.063 | Frequency of binding sites i.e., number of ligands bound per nucleotide | ChEMBL. | 6854590 |
Activity (binding) | Increase in SIRT1 (unknown origin) deacetylation activity at 10 uM | ChEMBL. | 25710081 | |
Activity (binding) | = 0.063 | Compound was evaluated for the frequency of the binding site that is the number of molecules bound to every nucleotide (1/n) | ChEMBL. | 6540313 |
Activity (binding) | = 15.87 | Compound was evaluated for the binding parameter by determining the number of nucleotides occluded by a bound angelicin (n) | ChEMBL. | 6540313 |
Activity (functional) | = 1.08 % | Induction of apoptosis in human Jurkat cells assessed as induction of loss of membrane potential at 2.5 uM after 2 hrs post-irradiation with 20 J/cm'2 by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 6.63 % | Induction of apoptosis in human Jurkat cells assessed as lysosomal dysfunction at 1 uM after 4 hrs post-irradiation with 2.5 J/cm'2 using acridine orange dye by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 9.82 % | Induction of apoptosis in human Jurkat cells assessed as lysosomal dysfunction at 1 uM after 2 hrs post-irradiation with 2.5 J/cm'2 using acridine orange dye by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 10.2 % | Cell cycle arrest in human Jurkat cells assessed as accumulation in G2/M phase at 1 uM irradiated with 20 J/cm'2 after 24 hrs by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 12.3 % | Cell cycle arrest in human Jurkat cells assessed as accumulation in G1 phase at 1 uM irradiated with 20 J/cm'2 after 24 hrs by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 15.03 % | Induction of apoptosis in human Jurkat cells assessed as lysosomal dysfunction at 2.5 uM after 2 hrs post-irradiation with 2.5 J/cm'2 using acridine orange dye by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 15.82 % | Induction of apoptosis in human Jurkat cells assessed as increase in mitochondrial ROS production at 2.5 uM after 6 hrs post-irradiation with 2.5 J/cm'2 by FACS analysis | ChEMBL. | 20627596 |
Activity (functional) | = 30.8 % | Cell cycle arrest in human Jurkat cells assessed as accumulation in subG1 phase at 1 uM irradiated with 20 J/cm'2 after 24 hrs by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 41.2 % | Induction of apoptosis in human Jurkat cells assessed as induction of loss of membrane potential at 2.5 uM after 4 hrs post-irradiation with 20 J/cm'2 by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 46.7 % | Cell cycle arrest in human Jurkat cells assessed as accumulation in S phase at 1 uM irradiated with 20 J/cm'2 after 24 hrs by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 50.85 % | Induction of apoptosis in human Jurkat cells assessed as lysosomal dysfunction at 2.5 uM after 4 hrs post-irradiation with 2.5 J/cm'2 using acridine orange dye by flow cytometry | ChEMBL. | 20627596 |
Activity (functional) | = 58.8 % | Induction of apoptosis in human Jurkat cells assessed as induction of loss of membrane potential at 2.5 uM after 4 hrs post irradiation with 20 J/cm'2 using JC1 staining by FACS | ChEMBL. | 20627596 |
Activity (functional) | = 98.92 % | Induction of apoptosis in human Jurkat cells assessed as induction of loss of membrane potential at 2.5 uM after 2 hrs post-irradiation with 20 J/cm'2 using JC1 staining by FACS | ChEMBL. | 20627596 |
Binding constant (binding) | = 560 | Association constant of the compound to an isolated site calf thymus DNA | ChEMBL. | 6854590 |
D50 (functional) | = 2.33e-17 | Compound was evaluated for the inhibition of RNA synthesis in Ehrlich Ascites tumor cells by irradiation (365 nm) at 1.9 x 10 e-5M | ChEMBL. | 7277384 |
D50 (functional) | = 2.5e-17 | Compound was evaluated for the inhibition of DNA synthesis in Ehrlich Ascites tumor cells by irradiation (365 nm) at 1.9 x 10 e-5M | ChEMBL. | 7277384 |
D50 (functional) | = 23.3 quanta*10e-18 | Compound was evaluated for its ability to inhibit RNA synthesis in ehrlich ascites tumor cells by irradiation(365 nM) | ChEMBL. | 7205886 |
D50 (functional) | = 23.3 quanta*10e-18 | Compound was evaluated for its ability to inhibit RNA synthesis in ehrlich ascites tumor cells by irradiation(365 nM) | ChEMBL. | 7205886 |
D50 (functional) | = 25 quanta*10e-18 | Compound was evaluated for its ability to inhibit DNA synthesis in ehrlich ascites tumor cells by irradiation(365 nM) | ChEMBL. | 7205886 |
D50 (functional) | = 25 quanta*10e-18 | Compound was evaluated for its ability to inhibit DNA synthesis in ehrlich ascites tumor cells by irradiation(365 nM) | ChEMBL. | 7205886 |
GI50 (functional) | = 1 uM | Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay | ChEMBL. | 26295175 |
IC50 (functional) | = 0.8 uM | Cytotoxicity of the compound against LoVo (human intestinal adenocarcinoma) cell line at 6.5 joule/cm**2 UVA dose | ChEMBL. | 15837311 |
IC50 (functional) | = 0.9 uM | Cytotoxicity of the compound against HL-60 (human fibrosarcoma) cell line at 3.2 joule/cm**2 UVA dose | ChEMBL. | 15837311 |
IC50 (functional) | = 0.9 uM | Cytotoxicity of the compound against LoVo (human intestinal adenocarcinoma) cell line at 3.2 joule/cm**2 UVA dose | ChEMBL. | 15837311 |
IC50 (functional) | = 0.9 uM | Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay | ChEMBL. | 19230658 |
IC50 (functional) | = 0.9 uM | Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay | ChEMBL. | 19230658 |
IC50 (functional) | = 0.9 uM | Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 0.9 uM | Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 0.9 uM | Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 0.9 uM | Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1 uM | Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1 uM | Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1.1 uM | Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay | ChEMBL. | 21397509 |
IC50 (functional) | = 1.2 uM | Cytotoxicity of the compound against HL-60 (human fibrosarcoma) cell line at 2.5 joule/cm**2 UVA dose | ChEMBL. | 15837311 |
IC50 (functional) | = 1.2 uM | Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 1.2 uM | Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1.5 uM | Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1.5 uM | Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 1.6 uM | Cytotoxicity of the compound against LoVo (human intestinal adenocarcinoma) cell line at 2.5 joule/cm**2 UVA dose | ChEMBL. | 15837311 |
IC50 (functional) | = 1.6 uM | Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay | ChEMBL. | 19230658 |
IC50 (functional) | = 1.6 uM | Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 2.5 uM | Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (binding) | = 2.5 uM | Inhibition of NF-KB p50 subunit/DNA interaction after 20 mins by EMSA | ChEMBL. | 20980154 |
IC50 (functional) | = 2.5 uM | Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (functional) | = 2.6 uM | Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (functional) | = 2.6 uM | Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (functional) | = 2.6 uM | Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 3.6 uM | Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | = 4.4 uM | Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay | ChEMBL. | 20627596 |
IC50 (functional) | > 10 uM | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | ChEMBL. | 25710081 |
IC50 (functional) | = 15.7 uM | Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (functional) | = 15.7 uM | Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT-1080 human fibrosarcoma cell line | ChEMBL. | 12873520 |
IC50 (functional) | = 15.7 uM | Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay | ChEMBL. | 18951030 |
IC50 (functional) | = 16 uM | Cytotoxicity of the compound against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM | ChEMBL. | 15837311 |
IC50 (functional) | = 16 uM | Cytotoxicity of the compound against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM | ChEMBL. | 15837311 |
IC50 (functional) | = 16 uM | Cytotoxicity of the compound against HL-60 (human fibrosarcoma) cell line; Range 0.4-16 uM | ChEMBL. | 15837311 |
IC50 (functional) | = 16 uM | Cytotoxicity of the compound against LoVo (human intestinal adenocarcinoma) cell line; Range 0.4-16 uM | ChEMBL. | 15837311 |
IC50 (functional) | > 20 uM | Cytotoxicity against human LoVo cells after 72 hrs by MTT assay | ChEMBL. | 19230658 |
IC50 (functional) | > 20 uM | Cytotoxicity against human K562 cells after 72 hrs by MTT assay | ChEMBL. | 19230658 |
IC50 (functional) | > 20 uM | Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay | ChEMBL. | 19230658 |
IC50 (binding) | > 500 uM | Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay | ChEMBL. | 22222157 |
ID50 (functional) | = 2.5e-17 quanta | Compound was evaluated for 50% inhibition of DNA synthesis in Ehrlisch ascites tumor cells by irradiation (365 nM) at 1.9 x 10e -5M incubated with [3H]-thymidine at 37 degree C (p 0.05) | ChEMBL. | 6540313 |
ID50 (functional) | = 2.5e-17 quanta | Compound was evaluated for 50% inhibition of DNA synthesis in Ehrlisch ascites tumor cells by irradiation (365 nM) at 1.9 x 10e -5M incubated with [3H]-thymidine at 37 degree C (p 0.05) | ChEMBL. | 6540313 |
Inhibition (binding) | = 9.5 % | Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay | ChEMBL. | 22222157 |
Inhibition (functional) | = 17.5 % | In vivo inhibition of epidermal DNA synthesis in mouse after topical application | ChEMBL. | 6854590 |
Inhibition (functional) | = 17.5 % | In vivo inhibition of epidermal DNA synthesis in mouse after topical application | ChEMBL. | 6854590 |
Inhibition (functional) | = 28 % | In vivo inhibition of epidermal DNA synthesis in mouse after oral administration | ChEMBL. | 6854590 |
Inhibition (functional) | = 28 % | In vivo inhibition of epidermal DNA synthesis in mouse after oral administration | ChEMBL. | 6854590 |
K (functional) | = 560 | Compound was evaluated for association constant in the calf thymus DNA | ChEMBL. | 7277384 |
K (binding) | = 560 | Compound was evaluated for the association constant to an isolated site of DNA | ChEMBL. | 6540313 |
Number (binding) | = 15.87 | Number of nucleotides occluded by a bound furocoumarin molecule | ChEMBL. | 6854590 |
Partition coefficient | = 120 | Partition coefficient of the compound between octanol and water | ChEMBL. | 6854590 |
Rate constant (functional) | = 0.011 min-1 | Compound was evaluated for rate constant in the calf thymus DNA | ChEMBL. | 7277384 |
Rate constant (ADMET) | = 0.011 min-1 | Rate constant of the photoreaction between compound and DNA. | ChEMBL. | 6854590 |
Rate constant (binding) | = 0.011 min-1 | Compound was evaluated for the binding parameter by determining rate constant | ChEMBL. | 6540313 |
Relative activity (functional) | = 0.28 | In vivo inhibition of epidermal DNA synthesis in mouse after topical application relative to that of 8-MOP | ChEMBL. | 6854590 |
Relative activity (functional) | = 0.71 | In vivo inhibition of epidermal DNA synthesis in mouse after oral administration relativ to that of 8-MOP | ChEMBL. | 6854590 |
S (ADMET) | 0 M l-1 | Water solubility of the compound; Not determined | ChEMBL. | 7205886 |
S (ADMET) | 0 ug ml-1 | Water solubility of the compound; Not determined | ChEMBL. | 7205886 |
S (ADMET) | = 20 ug ml-1 | Water solubility of the compound (solubility in mol/L) | ChEMBL. | 7277384 |
Solubility | = 0.000105 M l-1 | Solubility of the compound in water was determined | ChEMBL. | 6854590 |
Solubility | = 20 ug ml-1 | Solubility of the compound in water was determined | ChEMBL. | 6854590 |
Specific radioactivity (ADMET) | = 1.59 Ci/M | Specific radioactivity of the compound. | ChEMBL. | 7205886 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 12873520 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
9 literature references were collected for this gene.